In this section : Oncology
Cancer of Unknown Primary
Prescribing Advice on Admission – Patients on Chemotherapy Regimes
Acute Oncology
Systemic Anticancer Therapy Toxicity
Lung Cancer
Neutropenic Sepsis
Oncology Contact Details & General Advice
Brain Tumours
Malignant Spinal Cord Compression
Systemic Anticancer Therapy Toxicity
Last updated 14th October 2021
- The Edinburgh Cancer centre provide a wealth of information on their NHS Lothian intranet
- You can access their Guidelines on Chemotherapy Toxicity by clicking here
- The toxicities covered are shown below.
Guidelines for Specific Toxicities
- Arthralgia management
- Constipation management
- Cytokine Release Syndriome Guidance
- Diarrhoea management
- Capecitabine Diarrhoea Info Sheet
- Irinotecan Diarrhoea Info Sheet
- Corticosteroid Induced Dyspepsia in Oncology/Haematology Patients
- EGFR inhibitor toxicity guideline
- Erlotinib/Tarceva/Aftinib EGFRi management
- Extravasation
- Hand Foot Syndrome management
- Hypersensitivity Guideline
- Hypertension giudeline with VEGF inhibitors
- Patient Group Directive – Hypersensitivity Reactions
- Ifosfamide-induced encephalopathy Protocol
- Screening for Fancosis Syndrome in patients receiving Ifosfamide
- Haemtaturia with Ifosfamide\Cyclophosphamide
- Magnesium Replacement Guidance
- Mucositis management
- Nausea management
- Neutropenic Sepsis Management
- Oxaliplatin Neurotoxicity Guidance
- Phosphate Replacement Guideline
- Proteinuria guideline with VEGF inhibitors
- Skin management
- VEGF inhibitor toxicity management
- Vomiting management
- Metoclopramide for symptoms including vomiting in the Palliative Care and Cancer Service
Immunotherapy
- Immunotherapy toxicity guideline
- Cancer Immunotherapy and Endocrine dysfunction
- GP Immunotherapy Information Letter
- GP Circular Information Sheet